Repeat screening for prostate cancer after 1-year followup in 984 biopsied men: clinical and pathological features of detected cancer.
about
A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer screening in Rotterdam, Netherlands.Advancements in magnetic resonance-guided robotic interventions in the prostate.The story of the European Randomized Study of Screening for Prostate Cancer.Technical considerations when obtaining and interpreting prostatic biopsies from men with suspicion of early prostate cancer: part I.Technical considerations when obtaining and interpreting prostatic biopsies from men with suspicion of early prostate cancer: part 2.The Clinical Value of Performing an MRI before Prostate BiopsyDetection rate of prostate cancer on the basis of the vienna nomogram: a singapore study.Predictors of prostate cancer on repeat transrectal ultrasound-guided systematic prostate biopsy.Features and preliminary results of the Dutch centre of the ERSPC (Rotterdam, the Netherlands).Clinical, biochemical and pathological features of initial and repeat transrectal ultrasonography prostate biopsy positive patients.Variation in patterns of practice in diagnosing screen-detected prostate cancer.The 20-core prostate biopsy as an initial strategy: impact on the detection of prostatic cancerCan Western based online prostate cancer risk calculators be used to predict prostate cancer after prostate biopsy for the Korean population?Human kallikrein-2 gene and protein expression predicts prostate cancer at repeat biopsy.Quality assessment for prostate-specific antigen (PSA) in relation to ERSPC: report of the PSA committee.
P2860
Q33642692-B9305BE7-BD5D-4837-826A-D9DEDC32EE2BQ34997228-48CC6306-18B4-4DED-BC0A-E9C0D90BAAC4Q35675436-5D031771-030A-47D2-A55A-4E2DAC63B63AQ36118574-EAC48946-49EA-4B02-9BE1-1C0ACE44D3F3Q36118580-86EDB2D8-1ED0-428A-A427-BE3FC76DB2B9Q38263045-34943215-7290-4D13-979C-8B81B1B0F337Q38780053-45C2487F-A70D-43B8-B7EB-7F0BF5425F8AQ39642058-3BBBC654-8376-4DEE-9CA4-FB00DBA945F8Q39677104-5D6C6EF3-41AD-405F-8A29-262E6B40A5BFQ39679092-485F676B-FE1F-4C4F-8B83-6D6AD950F84DQ39703434-5258282B-A00F-47B3-B8E3-4D3FAB56EE48Q39803711-DCCB4C32-5208-4464-A231-618A21A28767Q40087634-2ECB040D-B92C-4253-88E5-CABFB848F916Q40226279-F5240C44-C5C7-4A78-9FB0-C30E81C89777Q51019666-F4661521-0474-47F1-89D9-DBEE5AC429F8
P2860
Repeat screening for prostate cancer after 1-year followup in 984 biopsied men: clinical and pathological features of detected cancer.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Repeat screening for prostate ...... l features of detected cancer.
@en
Repeat screening for prostate ...... l features of detected cancer.
@nl
type
label
Repeat screening for prostate ...... l features of detected cancer.
@en
Repeat screening for prostate ...... l features of detected cancer.
@nl
prefLabel
Repeat screening for prostate ...... l features of detected cancer.
@en
Repeat screening for prostate ...... l features of detected cancer.
@nl
P2093
P1476
Repeat screening for prostate ...... l features of detected cancer.
@en
P2093
A E Kruger
C H Bangma
F H Schröder
J B Rietbergen
R F Hoedemaeker
W J Kirkels
P304
P356
10.1097/00005392-199812010-00046
P407
P433
P577
1998-12-01T00:00:00Z